Little is understood of the anatomical fate of activated T lymphocytes and the consequences they have on the tissues into which they migrate. Previous work has suggested that damaged lymphocytes migrate to the liver. This study compares class I versus class II major histocompatibility complex (MHC)–restricted ovalbumin-specific T cell antigen receptor (TCR) transgenic mice to demonstrate that after in vivo activation with antigen the emergence of CD4−CD8−B220+ T cells occurs more frequently from a CD8+ precursor than from CD4+ T cells. Furthermore, this change in phenotype is conferred only by the high affinity native peptide antigen and not by lower affinity peptide variants. After activation of CD8+ cells with only the high affinity peptide, there is also a dramatically increased number of liver lymphocytes with accompanying extensive hepatocyte damage and elevation of serum aspartate transaminase. This was not observed in mice bearing a class II MHC–restricted TCR. The findings show that CD4−CD8−B220+ T cells preferentially derive from a CD8+ precursor after a high intensity TCR signal. After activation, T cells can migrate to the liver and induce hepatocyte damage, and thereby serve as a model of autoimmune hepatitis.
Skip Nav Destination
Article navigation
21 September 1998
Article|
September 21 1998
Liver Damage Preferentially Results from CD8+ T Cells Triggered by High Affinity Peptide Antigens
Jennifer Q. Russell,
Jennifer Q. Russell
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Search for other works by this author on:
Gregory J. Morrissette,
Gregory J. Morrissette
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Search for other works by this author on:
Mark Weidner,
Mark Weidner
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Search for other works by this author on:
Chirag Vyas,
Chirag Vyas
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Search for other works by this author on:
Deborah Aleman-Hoey,
Deborah Aleman-Hoey
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Search for other works by this author on:
Ralph C. Budd
Ralph C. Budd
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Search for other works by this author on:
Jennifer Q. Russell
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Gregory J. Morrissette
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Mark Weidner
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Chirag Vyas
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Deborah Aleman-Hoey
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Ralph C. Budd
From the Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Address correspondence to Ralph C. Budd, The University of Vermont College of Medicine, Given Medical Bldg., Burlington, VT 05405-0068. Phone: 802-656-2286; Fax: 802-656-3854; E-mail: [email protected]
Received:
April 16 1998
Revision Received:
June 17 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (6): 1147–1157.
Article history
Received:
April 16 1998
Revision Received:
June 17 1998
Citation
Jennifer Q. Russell, Gregory J. Morrissette, Mark Weidner, Chirag Vyas, Deborah Aleman-Hoey, Ralph C. Budd; Liver Damage Preferentially Results from CD8+ T Cells Triggered by High Affinity Peptide Antigens . J Exp Med 21 September 1998; 188 (6): 1147–1157. doi: https://doi.org/10.1084/jem.188.6.1147
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement